JPRN-jRCT1070210108Active, not recruiting未知
Examination of the rating system of peripheral neuropathy by oxaliplatin, paclitaxel using the nerve conduction survey instrument and nab paclitaxel
Takashi Inagaki0 sites30 target enrollmentStarted: January 13, 2022Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •1) We have unresectable progress, recurrence digestion ductal carcinoma (esophageal cancer, gastric cancer or colorectal cancer), pancreatic cancer.
- •2) We plan to receive chemotherapy including oxaliplatin or paclitaxel or nab paclitaxel.
- •3) There is no peripheral neuropathy before start of therapy subjectively.
- •4) Performance Status (PS): It is ECOG 2 or less.
- •5) A major organ function is kept enough.
- •6) An agreement is obtained in a document from patients about study entry.
Exclusion Criteria
- •1) We have the brain metastasis with the symptom.
- •2) We have diabetes mellitus inadequate control.
- •3) We judge the medical attendant to be inadequate as an object of this study.
Investigators
Similar Trials
Completed
Not Applicable
The Evaluation of new continuous peripheral nerve catheterOsteoarthritis , Injuries of leg, anterior cruciate ligament meniscus , FractureJPRN-UMIN000019895Department of anesthesiology , Wakayama medical school40
Not yet recruiting
Not Applicable
The examination of the effect of the peripheral nerve continuance block under the supersonic wave guideWhether there is an equal analgesic effect in a peripheral nerve block with supersonic wave guide and epidural blockJPRN-UMIN000005230Department of anesthesiology KM60
Recruiting
Not Applicable
Evaluation of a newly developed scoring system for detection of early pancreatic cancer: A prospective study.-The detection of stage 0 pancreatic cancerPancreatic cancerJPRN-UMIN000031969Oita San-ai Medical Center500
Completed
Not Applicable
Evaluation of a newly developed scoring system for detection of early pancreatic cancer: A prospective multi center study.Pancreatic cancerJPRN-UMIN000033092ew Tokyo Hospital3,500
Recruiting
Not Applicable
Evaluation of a newly developed scoring system for detection of early pancreatic cancer: A prospective multi center observational study.Pancreatic cancerJPRN-UMIN000034832Oita San-ai Medical Center7,000